The Role of Recombinant Secretory Leukocyte Protease Inhibitor to CD163, FGF-2, IL-1 and IL-6 Expression in Skin Wound Healing.
Elly MunadzirohGiovani Anggasta PutriVera RistianaTitien Hary AgustantinaIntan NirwanaFathilah Abdul RazakMeircurius Dwi Condro SurboyoPublished in: Clinical, cosmetic and investigational dermatology (2022)
The administration of rSLPI is able to accelerate the wound healing process by increasing the CD163 and FGF-2 expression. The cytokines such as IL-1 and IL-6 decreased depending on rSLPI doses.